Does Stripe Allow Peptides? What Stripe's Policy Says

Yes, with limitations, according to Stripe's own support FAQ. Its answer to "My business is not a pharmacy. May I sell peptides?" begins: "Yes, Stripe supports the sale of many different peptides, with some limitations." For research peptides it sets one condition: "Peptides that are for research purposes may be sold on Stripe as long as there are preventive measures in place to ensure these are not accessible to those who would purchase research chemicals for nonresearch purposes." The same FAQ says how Stripe treats peptides listed with no stated purpose, so a research store has to state the research purpose. We read the Stripe FAQ on October 26, 2026.

Updated October 26, 2026: an earlier version of this guide said Stripe's restricted businesses list never names peptides and stopped there. That was true of the list page, but Stripe's support FAQ, which the list page points to, answers the question directly. We corrected the opening, the key facts and the FAQ below.

The list page still matters. Stripe's prohibited and restricted businesses page, read on October 8, 2026, prohibits "incorrectly labeled research chemicals" and puts pharmaceuticals and prescription-only products in a restricted category it "might not be able to grant approval" for, and it says any approval "may be modified or revoked by Stripe at any time."

To compare what each processor's published pages ask a store to provide, use the payment processor requirements tool.

This guide is for founders of research use only (RUO) peptide stores deciding whether to apply to Stripe, or already on it. It reads every prohibited and restricted line a research peptide store can touch, sets FDA's two August 2026 warning letters beside them, and ends with an application checklist and a review pack. It cannot tell you what Stripe will decide, because nothing Stripe published says that.

Talk through your processor application before you submit it: book a call

What you will be able to do after reading

By the end of this guide you will be able to:

1. Find every prohibited line on Stripe's page that a research peptide store can touch, and say why each one matters. Delivered in Which prohibited lines can a research peptide store touch?.

2. Explain the restricted pharmaceuticals category, what its due diligence asks for, and why an approval can change. Delivered in Which restricted category covers pharmaceuticals, and what does its due diligence ask for? and What does "may be modified or revoked" mean for the operator?.

3. Explain why a research use only label did not settle the question in FDA's August 2026 letters. Delivered in Does a research use only label settle the question?.

4. Prepare an honest application in five steps and keep your store's copy consistent with it. Delivered in How do you prepare an honest Stripe application? and How do you keep the store's copy consistent with the application?.

5. Assemble the document pack you would need if the account is reviewed or closed. Delivered in What should you have ready if the account is reviewed or closed?.

The self check near the end tests each one.

Key Facts

• Stripe's support FAQ answers "My business is not a pharmacy. May I sell peptides?" with "Yes, Stripe supports the sale of many different peptides, with some limitations." Research peptides need "preventive measures" against buyers "who would purchase research chemicals for nonresearch purposes," read on October 26, 2026 (Stripe FAQ).
• Stripe's prohibited and restricted businesses page itself does not use the word peptide, by our count of the captured page, read on October 8, 2026 (Stripe).
• It prohibits "Incorrectly labeled research chemicals" and "Pseudo-pharmaceuticals or nutraceuticals that are not safe or make harmful claims."
• It prohibits "Illegal drugs, substances designed to mimic illegal drugs, including kava" and "Equipment and items intended to be used for making or using drugs."
• It prohibits "Any other products or services that are in violation of law in the jurisdictions where your business is located or to which your business is targeted."
• Its prohibited list "is not an exhaustive list."
• Pharmaceuticals and prescription-only products are a restricted category that "require[s] additional due diligence," including "Card-not-present prescription-only products and pharmaceuticals."
• Any approval "is specific to each service offer, and it may be modified or revoked by Stripe at any time per the terms of the Stripe Services Agreement."
• Among prohibited uses, Stripe lists selling products "that weren't disclosed in the business's Stripe account application" and says changes to business information must be notified "immediately."
• In two warning letters dated August 24, 2026, FDA found that evidence from each seller's website established the products "are intended to be drugs for human use," despite research use labeling (FDA, NuScience Peptides LLC; FDA, Peptide Partners LLC).

How is Stripe's page organized, and which parts matter to a peptide store?

Stripe's page opens with a short "How to use this page" section. It says the page "provides information on the types of businesses, products, and industries that can't use Stripe's services" and that "To use Stripe's services, you must remain compliant with these rules and restrictions." The capture we read carries the line "Last updated: 2026-09-22," and its change note for that update mentions tobacco and credit monitoring, not health products. Source: Stripe, Prohibited and Restricted Businesses.

By our reading of the captured page, it has six parts: high-risk jurisdictions and persons, prohibited businesses, restricted businesses, jurisdiction-specific prohibited businesses, prohibited uses of Stripe products, and restrictions for Stripe Issuing and Stripe Capital. Stripe explains why the page exists in its own words: "As a financial services company, we have to adhere to financial laws and regulations, as well as rules and policies set by our financial partners, such as card networks and banking partners." Source: Stripe, Prohibited and Restricted Businesses.

For a research peptide store, three parts carry almost all the weight:

• Prohibited Businesses. Lines that, if they describe your store, mean you "must not use Stripe's services."
• Restricted Businesses. Categories that "require additional due diligence by Stripe in order to confirm our ability to support them."
• Prohibited Uses of Stripe Products. Conduct that is barred whatever you sell, including what you put in your application.

The Issuing and Capital sections concern Stripe's card issuing and financing products; in our reading they do not decide whether a store can take card payments. A practical way to use the page: search it for every word your own catalog uses (research, chemical, pharmaceutical, prescription, drug, nutraceutical) and note each line that comes back. Source: Stripe, Prohibited and Restricted Businesses.

Which prohibited lines can a research peptide store touch?

This section delivers outcome 1 of 5: find the prohibited lines that reach your store.

Stripe's Prohibited Businesses section begins: "You must not use Stripe's services for any illegal activities or for the businesses or product types listed below." The lines below are the ones we read as reachable by a store that sells research peptides, reconstitution supplies and related content. Each heading quotes Stripe's own words. Source: Stripe, Prohibited and Restricted Businesses.

"Incorrectly labeled research chemicals"

This is the line closest to the research peptide model, and it is short. Stripe lists "Incorrectly labeled research chemicals" in the prohibited section, under the group headed "Illegal weapons, explosives, and dangerous materials," next to "Toxic, flammable, combustible, or radioactive materials" and "Unmailable goods, per the United States Postal Service." Source: Stripe, Prohibited and Restricted Businesses.

Stripe does not define "incorrectly labeled" on the page we read, does not say what a correct label would contain, and does not say that correctly labeled research chemicals are supported. In our reading, the line puts the label itself under review: a research use only statement is not the end of the question, because the rest of the store can contradict it. That is the reading FDA took in August 2026, covered below.

"Pseudo-pharmaceuticals or nutraceuticals that are not safe or make harmful claims"

Stripe groups this line under its own heading, "Nutraceuticals and pseudo-pharmaceuticals," and it is the only line in that group. Our site's payment processor tool records this rule text as its evidence quote for Stripe. Source: Stripe, Prohibited and Restricted Businesses.

The line has two triggers joined by "or": products that "are not safe," and products that "make harmful claims." Stripe defines neither. In our reading, a product page that reads like a supplement or a medicine (benefit, outcome or before and after language) invites this line whatever the label says. The fix sits in your copy, not your label.

"Illegal drugs, substances designed to mimic illegal drugs, including kava"

This is the first line in Stripe's prohibited section, under "Any illegal products and services." The next line is "Equipment and items intended to be used for making or using drugs." Source: Stripe, Prohibited and Restricted Businesses.

These lines do not name peptides or prescription products. In our reading they matter to a peptide store for one reason: the accessories line turns on intent ("intended to be used"), and FDA's August letters drew intent from what a store sold together. Both letters say that selling reconstitution water alongside the peptides "demonstrates that you intend" it "to be used in combination for injection." Whether Stripe would read a bundled accessory the same way, its page does not say. Sources: Stripe, FDA, Peptide Partners LLC.

"Any other products or services that are in violation of law"

The full line reads "Any other products or services that are in violation of law in the jurisdictions where your business is located or to which your business is targeted." It closes the "Any illegal products and services" group. Source: Stripe, Prohibited and Restricted Businesses.

This is the line that connects Stripe's page to FDA. In both August 2026 letters FDA wrote that "The introduction or delivery for introduction into interstate commerce of these unapproved new drug products violates sections 301(d) and 505(a) of the FD&C Act." In our reading, a store whose products FDA has called unapproved new drugs has a hard time arguing that this Stripe line does not reach it. Whether a given store is in violation of law is a question for counsel and, in the end, for regulators, not for this guide. Sources: Stripe, FDA, NuScience Peptides LLC.

"Unmailable goods" and "Illegally imported or exported products"

Two more prohibited lines can reach a store that ships physical product: "Unmailable goods, per the United States Postal Service" and, under the intellectual property group, "Illegally imported or exported products." Source: Stripe, Prohibited and Restricted Businesses.

Our sources do not say whether any peptide product is unmailable or what import rules apply to a shipment. In our reading, a store that imports finished goods should be able to show where each lot came from and how it entered the country before it applies.

Claims, testimonials and offers under "Unfair, deceptive, or abusive acts or practices"

Another prohibited group covers "Unfair, deceptive, or abusive acts or practices." Several lines in it describe store copy and offers rather than products:

• "Businesses that make outrageous claims, use deceptive testimonials, use high-pressure upselling, or use fake testimonials (with or without a written contract)"
• "Businesses offering unrealistic incentives or rewards as an inducement to purchase products or services"
• "Negative option marketing, negative option membership clubs, and reduced price trials with unclear or hidden pricing"
• "Any other businesses that Stripe considers unfair, deceptive, or predatory towards consumers"

Source: Stripe, Prohibited and Restricted Businesses.

In our reading, the testimonial line is easy for a research store to trip over, because a customer review that describes what a product did for the reviewer is both a testimonial and a use claim. The last line gives Stripe a general discretion ("that Stripe considers"), so a store cannot rely on fitting between the named lines. If you run subscriptions or auto refills, the negative option line asks that pricing and renewal terms be clear before the first charge.

The list "is not an exhaustive list"

Stripe says of its prohibited section: "The types of businesses listed here are representative of prohibited categories, but this is not an exhaustive list." It says the same of its restricted list: "The types of businesses listed below are representative of our restricted businesses but not exhaustive." Source: Stripe, Prohibited and Restricted Businesses.

So the missing word peptide on the list page proves very little either way: absence from a sample list is not an approval, and Stripe answers the peptide question in its FAQ, not on the list.

Which restricted category covers pharmaceuticals, and what does its due diligence ask for?

This section delivers outcome 2 of 5: explain the restricted pharmaceuticals category.

Stripe's restricted section opens with the rule that governs every category in it: "Businesses in these categories require additional due diligence by Stripe in order to confirm our ability to support them." It then says what that diligence looks like at sign up: "When you create your Stripe account, you will be asked to provide additional information (such as proof of relevant licenses or more details about your business model) to confirm your eligibility to use Stripe." Source: Stripe, Prohibited and Restricted Businesses.

The lines under "Pharmaceuticals, medical devices, and telemedicine"

Under the heading "Pharmaceuticals, medical devices, and telemedicine (see the FAQs for additional details)," Stripe lists five lines:

• "Online pharmacies, including SaaS platforms"
• "Card-not-present prescription-only products and pharmaceuticals"
• "Prescription-only and regulated medical devices"
• "Prescription delivery services"
• "Telemedicine and telehealth services"

Source: Stripe, Prohibited and Restricted Businesses.

For an online store the key line is the second one. Every sale on a website is card-not-present, so if any product in your catalog is a pharmaceutical or a prescription-only product, the line describes your checkout. Our site's payment processor tool records this line as the additional rule text for Stripe. The page points to its FAQs for more detail, and the FAQ has a peptides answer. It says: "A large number of peptides are prescription only and are required to be sold by pharmacies, meaning Stripe must preapprove the merchant." And for research peptides: "Peptides that are for research purposes may be sold on Stripe as long as there are preventive measures in place to ensure these are not accessible to those who would purchase research chemicals for nonresearch purposes." Source: Stripe FAQ, read October 26, 2026.

Why a research store cannot pick this category and stay a research store

In our reading, this is the central tension for a research peptide store, and Stripe's FAQ narrows it without removing it: research peptides are allowed only with preventive measures against nonresearch buyers, and the FAQ text we read does not list what those measures must be. The restricted category is written for businesses that sell pharmaceuticals and say so, and its due diligence asks for "proof of relevant licenses." A research use only store usually tells Stripe its products are research materials, not pharmaceuticals. If FDA's reading in August 2026 applies to a store's catalog, those same products are drugs, which points to the restricted category, where the store holds no license to show. The store then sits between two lines: research chemicals that may be "incorrectly labeled," or pharmaceuticals without the licenses the diligence asks for. Sources: Stripe, FDA, Peptide Partners LLC. None of that is a Stripe statement; the outcome of any application is Stripe's call.

"Might not be able to grant approval"

Stripe gives its reasons before the list: "Due to card network rules, requirements of financial partners, and our own compliance and legal obligations, if your business falls into one of the categories below, Stripe might not be able to grant approval for your business to use our products." Source: Stripe, Prohibited and Restricted Businesses.

The sentence names three sources of the limit, and two of them sit outside Stripe: card network rules and its financial partners. In our reading, that means a good relationship with a Stripe contact cannot override the result, because the rule may not be Stripe's to waive.

What does "may be modified or revoked" mean for the operator?

The full sentence reads: "If we do provide approval, note that the approval is specific to each service offer, and it may be modified or revoked by Stripe at any time per the terms of the Stripe Services Agreement." Source: Stripe, Prohibited and Restricted Businesses.

Approval is "specific to each service offer"

An approval covers the offer Stripe reviewed. In our reading, no store should assume an approval covers products added later, a second storefront, or a new sales channel. Stripe's prohibited uses section points the same way: it says "If there are any changes to your personal and business information, you must notify Stripe immediately." A practical way to handle this is to treat every catalog change as a question to put to Stripe in writing before launch, not after. Source: Stripe, Prohibited and Restricted Businesses.

"At any time"

The approval can change after it is granted, and the page we read states no notice period. The page also says: "To use Stripe's services, you must remain compliant with these rules and restrictions." In our reading, the word "remain" makes compliance a running test. An account that passed review in one month can be reviewed again when the catalog, the copy or the risk picture changes. Source: Stripe, Prohibited and Restricted Businesses.

"Per the terms of the Stripe Services Agreement"

The revocation sentence points to the Stripe Services Agreement for how changes happen. The sources we hold do not include that agreement, so this guide does not say what it provides about notice, reserves, payouts or termination. Read your own copy before you apply and keep the version you accepted.

One more line is often quoted in this context, and it needs care. Stripe's page says "Failure to comply within the requested time frames might result in the closure of your Stripe account," and that its compliance teams "might ask you to update your marketing materials or aspects of your user experience." Both sentences sit in the section on Stripe Issuing, the card issuing product. We do not read them as a rule for card acceptance, but they show the kind of request Stripe's compliance teams describe making. Source: Stripe, Prohibited and Restricted Businesses.

Which prohibited uses apply whatever you sell?

Stripe's "Prohibited Uses of Stripe Products" section applies regardless of industry. The page describes it as activities for which "Stripe may never be used," and several lines speak directly to how a research peptide store applies and operates:

• "Use of Stripe products with false, manipulated, inaccurate, or misleading information regarding your identity, business entity, the nature of the business, and any other information requested by Stripe"
• "If there are any changes to your personal and business information, you must notify Stripe immediately"
• "Use of Stripe products to facilitate transactions on behalf of another undisclosed merchant or for products or services that weren't disclosed in the business's Stripe account application"
• "Use of Stripe principally as a virtual terminal (for example, submitting card transactions by manually inputting card information)"
• "Processing where there is no bona fide good or service sold, or donation accepted; card testing"
• "Evasion of card network chargeback monitoring programs"
• "Sharing cardholder information with another business for payment of cross-sell of products or services"

Source: Stripe, Prohibited and Restricted Businesses.

What these lines mean in practice

The nature of the business. The first line covers "the nature of the business," not only identity. In our reading, describing a research peptide store as something it is not (a generic wellness shop, a software business) is this conduct, a problem separate from any product line.

Undisclosed products and merchants. The third line also covers "another undisclosed merchant." In our reading, that reaches a checkout that processes orders for a supplier, sister brand or wholesale partner Stripe never reviewed.

Phone and chat orders. Keying in card numbers taken by message is close to the virtual terminal line. Route every order through the checkout you described.

Chargebacks. In our reading, splitting volume across accounts to stay under a dispute threshold is what "Evasion of card network chargeback monitoring programs" describes. Lower disputes at the source instead: clear descriptions, shipping times and refund terms.

Endorsement. The page also prohibits "any action that implies an untrue endorsement by, or affiliation, with Stripe." In our reading, a badge or line of copy suggesting Stripe approved your products is this kind of action. Source: Stripe, Prohibited and Restricted Businesses.

Does a research use only label settle the question?

This section delivers outcome 3 of 5: explain why the label did not settle it.

No published source we hold says it does, and FDA's two August 2026 letters say the opposite for the stores they reviewed. Both are dated August 24, 2026, both were issued by FDA's "Center for Drug Evaluation and Research (CDER)," and both open the same way: "This warning letter advises you of significant violations observed during a U.S. Food and Drug Administration (FDA) review of your website." Sources: FDA, NuScience Peptides LLC, FDA, Peptide Partners LLC.

What the labels said, and what FDA wrote about them

The labels were not missing. FDA quoted them. In the letter to NuScience Peptides LLC, footnote 1 reads: "Despite statements on your product labeling marketing your products "for laboratory, research, and analytical use" and "not intended for human or veterinary use," evidence obtained from your website establishes that your products are intended to be drugs for human use." Source: FDA, NuScience Peptides LLC.

The letter to Peptide Partners LLC has the same structure with different label wording. Its footnote quotes labels reading "for research use only" and "not for human or veterinary use," and reaches the same finding: "evidence obtained from your website establishes that your products are intended to be drugs for human use." Source: FDA, Peptide Partners LLC.

Two label formulas, one result. In our reading, the evidence around the label, not its wording, decided both letters.

The legal hook: intended use

FDA tied its finding to the intended use regulation. Both letters say the listed products "are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body." The NuScience letter introduces its examples as ones "from your product labeling, including on your website, that provide evidence of the intended use (as defined in 21 CFR 201.128) of these products as drugs." Source: FDA, NuScience Peptides LLC.

The regulation itself says intended use refers to "the objective intent of the persons legally responsible for the labeling of an article (or their representatives)," and that "This objective intent may, for example, be shown by labeling claims, advertising matter, or oral or written statements by such persons or their representatives." It adds that intent may be shown "by the circumstances surrounding the distribution of the article." Source: 21 CFR 201.128.

In our reading, that is why a label alone cannot carry the weight: the regulation looks at the copy, the ads, the seller's messages and what is sold alongside what.

What evidence did FDA cite?

The letters cite three kinds of evidence, and each one maps to a part of a store an operator controls.

1. Product page text that summarized studies. FDA quoted product pages. On the Peptide Partners pages, FDA quoted seller copy that summarized study findings about a named weight management compound and about bone tissue. On the NuScience pages, FDA quoted seller copy that summarized clinical trial reports for weight management and metabolic conditions. Many of the quoted passages were framed as summaries of laboratory or animal research, and FDA still cited them as evidence of intended use. Sources: FDA, Peptide Partners LLC, FDA, NuScience Peptides LLC.

2. What was sold together. Both letters treat reconstitution water as a drug because of the catalog around it. The NuScience letter says: "The sale of these products together demonstrates that you intend for your "Bacteriostatic water for Peptides (BAC Water)" to be used in combination for injection." The Peptide Partners letter says the same of its "Reconstitution Solution (BAC)." Sources: FDA, NuScience Peptides LLC, FDA, Peptide Partners LLC.

3. Tools and supporting content. The NuScience footnote adds: "In addition to the cited drug claims, you market bacteriostatic water alongside a "peptide calculator," a resource that provides the means to prepare an injectable drug for human administration." The Peptide Partners footnote says the seller marketed bacteriostatic water "as a solvent for reconstituting your products, thus, providing the means to prepare an injectable drug for human administration." Sources: FDA, NuScience Peptides LLC, FDA, Peptide Partners LLC.

Both letters also say: "This is not intended to be an all-inclusive list of the violations that may exist in connection with your products or operations." The evidence above is what FDA chose to cite, not a complete map. Source: FDA, Peptide Partners LLC.

What FDA asked for, and why a processor cares

Each letter asks for a written response "within fifteen (15) business days of receipt of this letter," with the steps taken to correct the violations and "copies of related documentation." The letters warn that "Failure to adequately address violations may result in regulatory or legal action without further notice including, without limitation, seizure and injunction." Each letter also notes: "Please note FDA posts warning letters on www.fda.gov." Source: FDA, NuScience Peptides LLC.

In our reading, that last sentence joins FDA to Stripe. A warning letter is public and names products, and Stripe's page asks whether products are "in violation of law" or "incorrectly labeled." Anyone reviewing a store can read such a letter. For a full read of the letters, see what FDA warning letters say about peptide marketing and the FDA warning letter tracker.

So what does "incorrectly labeled" mean for your store?

Stripe does not define it, so any answer is judgment. Ours: a research label is most exposed when anything else in the catalog, ads or messages points to a use the label denies. FDA's letters show a regulator reading a label against the rest of a website and preferring the rest. The whole store has to say what the label says. For the label itself, see research use only peptides: meaning and limits.

How do you prepare an honest Stripe application?

This section delivers outcome 4 of 5: prepare an honest application.

Stripe's page gives you the standard: no "false, manipulated, inaccurate, or misleading information regarding your identity, business entity, the nature of the business, and any other information requested by Stripe," and no products "that weren't disclosed in the business's Stripe account application." An honest application is one a reviewer could check against your live store and find nothing new. Source: Stripe, Prohibited and Restricted Businesses.

These steps are our recommendation and do not predict approval.

Step 1: describe the business in plain words

Say what you sell, to whom, and how. If you sell research peptides, say research peptides. In our reading, a vague category chosen to avoid review is the "nature of the business" problem Stripe names.

Step 2: list every product line, including accessories and content

Write a full product list before you start the form: every compound, every size, every bundle, every accessory, and every non product item (calculators, guides, subscriptions). Then compare it with the store. FDA's letters show why accessories and tools belong on the list: the reconstitution water and the "peptide calculator" were cited as evidence about the rest of the catalog. Sources: Stripe, FDA, NuScience Peptides LLC.

Step 3: read your own store against Stripe's lines

Mark the lines quoted above, each one as does not describe us, could describe us, or describes us. Keep that sheet with the application. If a line describes your store, the honest options are to change the store before applying, or to accept that the line applies and not apply.

Step 4: decide what you will say about pharmaceuticals

Stripe's restricted category covers "Card-not-present prescription-only products and pharmaceuticals," and its diligence asks for "proof of relevant licenses." If your catalog includes anything sold as a pharmaceutical or prescription product, you are in that category and should expect that request. If your position is that nothing in your catalog is a pharmaceutical, our recommendation is that you be able to explain why, in writing, with your counsel's help, before you put it in the form. Source: Stripe, Prohibited and Restricted Businesses.

Step 5: make the store match the application before you submit

Apply only once the live site says what the application says. A reviewer sees the store as it is on the day they look. Our peptide merchant account underwriting checklist walks through the pages and policies a reviewer typically reads.

How do you keep the store's copy consistent with the application?

Approval is "specific to each service offer," and Stripe asks you to report changes "immediately," so tell Stripe before a new line goes live. Consistency is a standing rule for every page, email and post, not a launch task. Source: Stripe, Prohibited and Restricted Businesses.

A copy audit, page by page

Our recommendation is a monthly audit that asks the same five questions of each surface:

1. Product pages. Does any sentence describe what the product does in a person or an animal, or summarize a study as a benefit? FDA quoted exactly that kind of sentence.

2. Bundles and cross sells. Does any bundle or frequently bought together block pair a research product with the means to prepare it for use in a person? FDA cited "The sale of these products together."

3. Tools and guides. Does the store offer calculators, protocols or how to content? The NuScience letter cited a "peptide calculator."

4. Reviews and testimonials. Does any review describe personal use or results? Stripe prohibits "deceptive testimonials" and "fake testimonials," and in our reading a use review on a research store contradicts the label.

5. Off site channels. Do emails, social posts, ads, affiliate pages or customer chats say anything the site does not? The intended use regulation counts "advertising matter, or oral or written statements" by the seller or its representatives.

Sources: FDA, NuScience Peptides LLC, Stripe, 21 CFR 201.128.

For how a product page can be laid out to keep the label and the copy aligned, see anatomy of a compliant peptide product page.

A worked consistency sheet

The sheet below is a worked example, not a template Stripe published. Fill one row per surface.

What should you have ready if the account is reviewed or closed?

This section delivers outcome 5 of 5: assemble your document pack.

Stripe's page says approval "may be modified or revoked by Stripe at any time," and that a business "must remain compliant." It does not describe a review process, timelines or payout handling; our sources do not include the Stripe Services Agreement. What you control is what you can show when asked. Source: Stripe, Prohibited and Restricted Businesses.

The document pack

Our recommendation: keep this pack current from day one.

• The application as submitted. The exact text, the date and the product list you disclosed.
• The current product list. Every live SKU with the date it was added and the date you told Stripe.
• Dated page captures. Each product page, the home page and the policies pages, captured monthly.
• The copy audit sheet. The rows above, with each fix and its date.
• Lot documents. A certificate of analysis for each lot you sell. Our site's COA checklist asks, among other things, "Does the report name the lab, the sample, the lot number and the dates?" and "Does the lot number on the report match the vial label?" See batch specific COA vs generic lot COA.
• Policies. Refund, shipping and terms pages, with the date each version went live.
• Dispute records. Each dispute, its reason and the evidence you sent.

If the account is closed or frozen

Our guide Peptide Merchant Account Frozen? What to Do in 72 Hours sets out the first three days step by step. Two points from Stripe's page matter here. First, do not open a second account to keep selling the same catalog without disclosing the history; the prohibited uses section bars "false, manipulated, inaccurate, or misleading information." Second, do not move volume to another account to stay under dispute thresholds; that is "Evasion of card network chargeback monitoring programs." Source: Stripe, Prohibited and Restricted Businesses.

For processors built for higher risk merchants, see high risk payment processing for peptide ecommerce.

What do PayPal and Braintree say, in brief?

PayPal's acceptable use policy lists "The sale of any product(s) requiring a prescription or prescription dispensing services," and says "Violation of this Acceptable Use Policy constitutes a violation of the PayPal User Agreement." Source: PayPal Acceptable Use Policy.

Braintree's acceptable use policy lists "prescription drugs, illegal drugs or substances designed to mimic illegal drugs" and "pseudo pharmaceuticals." It also says that if it believes you may have violated the policy, "we may (with or without notice to you) take such actions as we deem appropriate," and those actions include "Terminating our business relationship with you." Source: Braintree Acceptable Use Policy.

For the side by side read, see Peptide Payment Processors Compared: What Stripe, PayPal, Square and Braintree Policies Say, and for wallets and pay later options at checkout, see PayPal, Apple Pay and Buy Now Pay Later on a Peptide Store.

Pre application checklist

Work through this before you open the Stripe form. Each item points to the Stripe line or FDA passage it comes from (Stripe, FDA, Peptide Partners LLC). The list is our recommendation, not a Stripe requirement.

1. I have read Stripe's prohibited and restricted page in full on the day I apply, and noted its "Last updated" date.

2. I have marked every prohibited and restricted line as does not describe us, could describe us, or describes us.

3. I have a written product list covering every SKU, bundle, accessory, tool and subscription.

4. My application names what the store sells in plain words, with no category chosen to avoid review.

5. I know whether anything I sell is a pharmaceutical or prescription product, and I have counsel's written view if I say it is not.

6. No product page describes what a product does in a person or animal, or presents study summaries as benefits.

7. No bundle or cross sell pairs a research product with the means to prepare it for use in a person.

8. No calculator, protocol, how to content or use review is live on the store.

9. Emails, social posts, ads, affiliate pages and chat scripts say nothing the site does not.

10. Every order runs through the hosted checkout I describe in the application, with no keyed in card numbers.

11. Refund, shipping and subscription terms are clear before the first charge.

12. No copy or badge suggests Stripe endorses or approved my products.

13. Every lot I sell has a certificate of analysis whose lot number matches the label.

14. I have saved a dated copy of the application, the product list and every product page.

15. I have a written rule to notify Stripe before any new product line goes live.

Self check

Answer each question before reading its answer. If you miss one, reread the section named after it.

1. Where does Stripe answer the peptide question, and what does it say?

In its support FAQ, not on the list page: "Yes, Stripe supports the sale of many different peptides, with some limitations." Research peptides need preventive measures against nonresearch buyers. See the opening and Does Stripe allow peptides? in the FAQ section.

2. Which prohibited line names research chemicals?

The line on incorrectly labeled research chemicals. See Which prohibited lines can a research peptide store touch?.

3. Is Stripe's prohibited list complete?

No. Stripe says it is not an exhaustive list. See Which prohibited lines can a research peptide store touch?.

4. Can an approval from Stripe change after it is granted?

Yes. Stripe says an approval is specific to each service offer and may be modified or revoked at any time under the Stripe Services Agreement. See What does "may be modified or revoked" mean for the operator?.

5. You plan to add a product line. What comes first?

Disclosure. Stripe lists selling products not disclosed in the account application among prohibited uses, and asks for changes to be notified immediately. See Which prohibited uses apply whatever you sell?.

6. Does your document pack hold dated captures of each product page, the home page and the policies pages?

It should: the pack lists them, captured monthly. See The document pack.

What you should have when you finish

• A dated, marked up copy of Stripe's page and a product list that matches the application word for word.
• A completed copy audit sheet with every fix dated.
• A written position, reviewed by counsel, on whether anything you sell falls under "Card-not-present prescription-only products and pharmaceuticals."
• A document pack (application, product list, page captures, COAs, policies, dispute records) you could send within a day of being asked.
• A rule for catalog changes: disclose first, launch second.

Frequently Asked Questions

Does Stripe allow peptides?

Yes, with limitations, according to Stripe's support FAQ read on October 26, 2026: "Yes, Stripe supports the sale of many different peptides, with some limitations." Research peptides may be sold "as long as there are preventive measures in place to ensure these are not accessible to those who would purchase research chemicals for nonresearch purposes." Prescription only peptides must be sold by pharmacies that Stripe preapproves. Source: Stripe FAQ.

Does Stripe's restricted businesses page mention peptides?

Not by name. The list page we read on October 8, 2026 does not use the word peptide, by our count. Stripe answers the peptide question in its FAQ instead (see above). It prohibits "Incorrectly labeled research chemicals" and lists "Card-not-present prescription-only products and pharmaceuticals" as restricted, and it says its lists are not exhaustive. Source: Stripe.

Is a research use only label enough to keep a store out of Stripe's prohibited lines?

Stripe's page does not say so, and it does not define "incorrectly labeled." In two August 2026 letters, FDA found website evidence established the products "are intended to be drugs for human use" despite research use labeling. Sources: Stripe, FDA.

What does Stripe ask for in its restricted category due diligence?

Stripe says you "will be asked to provide additional information (such as proof of relevant licenses or more details about your business model) to confirm your eligibility to use Stripe." It also says it "might not be able to grant approval." Source: Stripe.

Can Stripe change an approval after it is given?

Yes. Stripe says an approval "is specific to each service offer, and it may be modified or revoked by Stripe at any time per the terms of the Stripe Services Agreement." Source: Stripe.

Do I have to tell Stripe when I add products?

Stripe's prohibited uses include selling products "that weren't disclosed in the business's Stripe account application," and it says "If there are any changes to your personal and business information, you must notify Stripe immediately." Source: Stripe.

Can customer reviews cause a problem with Stripe?

They can. Stripe prohibits "Businesses that make outrageous claims, use deceptive testimonials, use high-pressure upselling, or use fake testimonials." In our reading, a review describing personal use also contradicts a research label. Source: Stripe.

Why does selling reconstitution water matter?

FDA wrote in both August 2026 letters that selling it with the peptides "demonstrates that you intend" it to be used "in combination for injection." Stripe also prohibits "Equipment and items intended to be used for making or using drugs." Sources: FDA, Stripe.

What should I do first if my Stripe account is closed?

Gather your document pack and follow the first 72 hours plan in our frozen account guide. Do not reopen under different information: Stripe bars "false, manipulated, inaccurate, or misleading information." Source: Stripe.

Related guides

• Peptide Payment Processors Compared: What Stripe, PayPal, Square and Braintree Policies Say
• Does Shopify Allow Peptides? What the Policies Say
• Peptide Merchant Account Underwriting Checklist
• Research Use Only Peptides Meaning and Limits
• Peptide Merchant Account Frozen? What to Do in 72 Hours

Sources

• Stripe, Prohibited and Restricted Businesses. Read October 8, 2026.
• U.S. Food and Drug Administration, Warning Letter 733652, NuScience Peptides LLC, August 24, 2026. Read October 8, 2026, recaptured October 25, 2026.
• U.S. Food and Drug Administration, Warning Letter 735063, Peptide Partners LLC, August 24, 2026. Read October 8, 2026, recaptured October 25, 2026.
• U.S. Electronic Code of Federal Regulations, 21 CFR 201.128, Meaning of "intended uses". Read October 8, 2026.
• PayPal, Acceptable Use Policy. Read October 8, 2026.
• Braintree, Acceptable Use Policy. Read October 8, 2026.
• Peptide Ecommerce site data: the payment processor requirements tool and the site's COA checklist, the site's own data.

This guide reports what FDA, Stripe, PayPal and Braintree published, as captured on October 8, 2026. It is not legal advice for your business.